BioPharma Dive November 22, 2024
Jonathan Gardner and Ned Pagliarulo

A prolific medical research and author, Marty Makary criticized the FDA and CDC for their decision-making during the pandemic, although he describes himself as pro-vaccine.

President-elect Donald Trump on Friday named Johns Hopkins University surgeon Marty Makary to lead the Food and Drug Administration, choosing a prolific medical researcher who bucked consensus on the necessity of frequent vaccination during the COVID-19 pandemic.

As FDA commissioner, Makary would oversee an agency of some 18,000 employees who assess new drugs and devices, review the performance of approved medicines and monitor food quality and safety. The agency typically evaluates and makes decisions on more than 50 new drug and biological products each year.

Makary, whose specialty is pancreatic surgery, is something of a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, FDA, Govt Agencies
Why FDA Commissioner Robert Califf is 'concerned' about the incoming administration
A flurry of health tech deals announced ahead of JPM
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
FDA offers new draft guidance to developers of AI-enabled medical devices
Chevron’s Fall And Its Impact On Medical AI

Share This Article